BlueSphere Bio (@BlueSphereBio) header
BlueSphere Bio (@BlueSphereBio) profile picture

Personalized T-cell therapies for hematologic malignancies and solid tumors.

Joined October 2021
Photo by BlueSphere Bio (@BlueSphereBio)Photo by BlueSphere Bio (@BlueSphereBio)Photo by BlueSphere Bio (@BlueSphereBio)Photo by BlueSphere Bio (@BlueSphereBio)Photo by BlueSphere Bio (@BlueSphereBio)Photo by BlueSphere Bio (@BlueSphereBio)Photo by BlueSphere Bio (@BlueSphereBio)Photo by BlueSphere Bio (@BlueSphereBio)Photo by BlueSphere Bio (@BlueSphereBio)Photo by BlueSphere Bio (@BlueSphereBio)
We're very excited to be chatting with Dr. Mark Shlomchik (@ShlomchikLab) from @PittTweet and @BlueSphereBio next week! His lab recently published a @JCI_Insight article identifying RUBICON as a novel regulator of #lupus. ๐Ÿ“Ž Check it out: bit.ly/3QsEQJc
1
1